Courtesy of Dr. Carlos Fava. Tricuspid regurgitation (TR) has a negative impact in the long run. Several reports have shown that, in high risk inoperable patients, transcatheter edge-to-edge valve repair with MitraClip is feasible, safe and has good results, but there is still a long way to go. The present study looked at 24 consecutive<a href="https://solaci.org/en/2018/08/21/more-evidence-for-mitraclip-in-high-risk-patients-with-severe-tricuspid-regurgitation/" title="Read more" >...</a>
See the list of winners for all contests carried out as part of the last SOLACI-SOCIME 2018 Congress. The names were announced on Friday, August 3rd, at the Congress closing ceremony. SOLACI-SOCIME 2018 Congress Best Abstract Award: Winners: Dr. Botelho Carlos, Dr. Padilla Lucio, Dr. Harada Ribeiro Marcelo, Dr Araya Mario, Dr. Ybarra Luis<a href="https://solaci.org/en/2018/08/15/solaci-socime-2018-congress-here-are-the-winners/" title="Read more" >...</a>
Courtesy of Dr. Carlos Fava. Transcatheter aortic valve replacement (TAVR) was developed for aortic stenosis, but there is a significant number of patients with severe aortic regurgitation who still undergo this procedure as an off-label indication. Current evidence for this procedure in relation with this disease is growing, mainly due to good results obtained by different<a href="https://solaci.org/en/2018/07/27/more-favorable-evidence-for-tavr-in-severe-aortic-regurgitation/" title="Read more" >...</a>
Nutritional status is associated with higher mortality in elderly patients with severe aortic stenosis who require valve replacement, whether through conventional surgical strategy or transcatheter aortic valve replacement (TAVR). Malnutrition is obviously associated with frailty. As an advantage, it can be quite evident to our clinical eye and weighing scales are enough to define it.<a href="https://solaci.org/en/2018/07/23/far-from-a-being-a-pun-malnutrition-tips-the-scales-in-tavr/" title="Read more" >...</a>
Left main coronary artery bifurcation interventions have shown very good results at long term, especially with new generation DES. The one-stent strategy has seen better results than the two-stent strategy, according to this registry recently published in J Am Coll Cardiol Intv. However, how does this registry of the daily practice between the years 2002 and<a href="https://solaci.org/en/2018/07/17/left-main-pci-despite-auspicious-long-term-outcomes-optimal-strategy-still-under-discussion/" title="Read more" >...</a>
The EXCEL study, originally presented at TCT 2016 and published simultaneously in the New England Journal of Medicine (NEJM), showed that angioplasty and surgery in patients with left main coronary artery disease have similar rates of mortality, infarction, and stroke at 3 years. This sub-study, recently published in J Am Coll Cardiol Intv, adds that the<a href="https://solaci.org/en/2018/07/17/excel-sub-study-the-site-of-the-left-main-coronary-artery-lesion-does-not-alter-history/" title="Read more" >...</a>
The participation of the medical industry is, undoubtedly, one of the most appealing aspects of the SOLACI-SOCIME 2018 Congress. As usual, the most important companies in this industry have decided to take part in our event. Their contribution is most valuable, as it brings relevance and improves the quality of our scientific presentations. Organize your<a href="https://solaci.org/en/2018/07/13/live-cases-edited-cases-and-lunch-symposiums-sponsored-by-the-industry/" title="Read more" >...</a>
The EXCEL trial did not find the sex of patients with left main coronary artery disease to be an independent predictor of adverse events after revascularization. However, women who underwent angioplasty had a trend towards worse outcomes, a finding that might be related to comorbidities and somewhat increased chances of peri-procedural complications. In its formal<a href="https://solaci.org/en/2018/07/10/should-sex-be-taken-into-account-with-left-main-coronary-artery-revascularization/" title="Read more" >...</a>
Courtesy of Dr. Carlos Fava. Mitral regurgitation accounts for around 25% of valvular diseases and is a strong mortality predictor in heart disease. One of the challenges of this disease is that patients respond favorably to medical treatment for a long time, which makes hard to establish the right time to perform an intervention without<a href="https://solaci.org/en/2018/07/05/mitraclip-in-severe-mr-5-year-mortality-rate-similar-to-surgery/" title="Read more" >...</a>
Endovascular therapy is now considered as the standard of care for acute ischemic stroke caused by large vessel occlusion. The time between symptoms onset and reperfusion emerges as the most determinant factor for good clinical outcomes, much more strongly than even in acute myocardial infarction. The saying “time is brain” is even more relevant than<a href="https://solaci.org/en/2018/07/04/endovascular-therapy-in-stroke-much-evidence-and-few-trained-operators/" title="Read more" >...</a>